FFAR1 and type 2 diabetes mellitus: Investigating G-protein-coupled receptor 40 (GPR40) as a novel therapeutic target for type 2 diabetes, Zhao et al. synthesized a series of 2-(disubstituted phenyl)-indole-5-propanoic acid derivatives.